DermaVir
a topical, DNA-based therapeutic immunization (DermaVir) designed to express most of the regulatory and structural viral genes in dendritic cells, used for control of viral rebound; can complement antiretroviral drugs to sustain suppression of HIV-1 replication
Networked: 9
relevant articles (2 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Lisziewicz, Julianna:
7 articles
(01/2013 - 01/2005)
|
2. | Lori, Franco:
6 articles
(10/2011 - 01/2005)
|
3. | Bakare, Nyasha:
3 articles
(09/2007 - 01/2005)
|
4. | Whitman, Lucia:
3 articles
(09/2007 - 01/2005)
|
5. | Tőke, Enikő R:
2 articles
(01/2013 - 05/2012)
|
6. | Trocio, Jeffrey N:
2 articles
(09/2008 - 09/2007)
|
7. | Arya, Suresh:
2 articles
(01/2005 - 01/2005)
|
8. | Trocio, Jeffrey:
2 articles
(01/2005 - 01/2005)
|
9. | Xu, Jianqing:
2 articles
(01/2005 - 01/2005)
|
10. | Chandran, Preethi L:
1 article
(05/2012)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures